Abhay Joshi
2015
In 2015, Abhay Joshi earned a total compensation of $5.6M as Chief Operating Officer at Revance Therapeutics.
Compensation breakdown
| Option Awards | $4,340,387 |
|---|---|
| Salary | $21,718 |
| Stock Awards | $1,248,500 |
| Total | $5,610,605 |
Joshi received $4.3M in option awards, accounting for 77% of the total pay in 2015.
Joshi also received $21.7K in salary and $1.2M in stock awards.
Rankings
In 2015, Abhay Joshi's compensation ranked 1,366th out of 13,638 executives tracked by ExecPay. In other words, Joshi earned more than 90.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,366 out of 13,638 | 90th |
Division Manufacturing | 474 out of 5,187 | 91st |
Major group Chemicals And Allied Products | 175 out of 1,857 | 91st |
Industry group Drugs | 133 out of 1,531 | 91st |
Industry Pharmaceutical Preparations | 110 out of 1,179 | 91st |
Source: SEC filing on March 24, 2017.
Joshi's colleagues
We found two more compensation records of executives who worked with Abhay Joshi at Revance Therapeutics in 2015.
News
Revance Therapeutics CEO Mark Foley's 2021 pay slips 19% to $7.1M
March 24, 2022
Revance Therapeutics CEO Mark Foley's 2020 pay falls 49% to $8.8M
March 11, 2021
Revance Therapeutics CEO Mark Foley receives $17M in 2019
March 26, 2020
Revance Therapeutics CEO L Browne's 2018 pay jumps 37% to $4.7M
March 25, 2019